This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Human Genome Sciences, Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Olivier Blondel: Innovator in Albumin Fusion Proteins
Introduction
Olivier Blondel is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of albumin fusion proteins.
Latest Patents
Olivier Blondel holds a patent for "Albumin fusion proteins comprising insulin polypeptides." This invention encompasses albumin fusion proteins and includes nucleic acid molecules encoding these proteins. The patent also covers vectors containing these nucleic acids, host cells transformed with these vectors, and methods for producing and utilizing these albumin fusion proteins. Additionally, the invention includes pharmaceutical compositions that utilize these proteins for treating, preventing, or ameliorating various diseases and disorders.
Career Highlights
Olivier Blondel is associated with Human Genome Sciences, Inc., where he has been instrumental in advancing research and development in the field of genetic sciences. His work has contributed to the understanding and application of albumin fusion proteins in medical treatments.
Collaborations
Throughout his career, Olivier has collaborated with esteemed colleagues such as Craig A. Rosen and Steven M. Ruben. These collaborations have fostered innovation and have been pivotal in the successful development of his patented technologies.
Conclusion
Olivier Blondel's work in the field of albumin fusion proteins exemplifies the impact of innovative thinking in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile